This is a secure website for access by authorized participants of the ALung VENT-AVOID Clinical Trial.  Please login to access the site.  To request access to this site please send an email to accounts@alung.com.

 

ALung is currently conducting a pivotal IDE trial of the Hemolung Respiratory Assist System for the treatment of adults with severe acute exacerbations of chronic obstructive pulmonary disease (COPD). The VENT-AVOID Trial is the first pivotal trial of extracorporeal carbon dioxide removal (ECCO2R) for treating patients with COPD exacerbations.